Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-025537

President and CEO sold 70,000 shares at an average $15.15 ($1,060,701)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2022-04-21 Sale −25,000 $15.24 $380,948 1,290,763 D
Walker Neal President and CEO 2022-04-22 Sale −25,000 $15.04 $376,098 1,265,763 D
Walker Neal President and CEO 2022-04-25 Sale −20,000 $15.18 $303,656 1,245,763 D
Open-market sales · 70,000 sh · avg $15.15 · $1,060,701
Loading xslF345X03/doc4.xml…